| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/19/2008 | CA2492836C Administration device comprising an osmotic drive |
| 02/19/2008 | CA2431565C Pharmaceutical compositions based on anticholinergics and ciclesonide |
| 02/19/2008 | CA2396152C Osmotic device within an osmotic device |
| 02/19/2008 | CA2387153C Chewing gum compositions |
| 02/19/2008 | CA2383977C Stably preserving oxygen infusion |
| 02/19/2008 | CA2369726C Powder inhaler for combined medicament |
| 02/19/2008 | CA2348024C Granular, free-flowing pharmaceutical composition, and straw-like dosage form for oral administration thereof |
| 02/19/2008 | CA2338901C Prevention of migraine recurrence |
| 02/19/2008 | CA2338629C Carrageenan compositions, and processes for their production |
| 02/19/2008 | CA2310049C Use of a mixture of a diol and an alpha-hydroxy acid for the treatment of hyperkeratotic skin diseases |
| 02/19/2008 | CA2301889C Water-soluble dry compositions |
| 02/19/2008 | CA2301723C Butyrate derivatives in the treatment of fibromyalgia and chronic fatigue syndrome |
| 02/19/2008 | CA2289702C High efficiency encapsulation of charged therapeutic agents in lipid vesicles |
| 02/19/2008 | CA2277207C Use of dichlorobenzyl alcohol for preparing a preparation for topical treatment of inflammation and a preparation containing dichlorobenzyl alcohol |
| 02/19/2008 | CA2273240C Compositions and methods for treating or preventing inflammatory diseases |
| 02/19/2008 | CA2265893C Oily patches for external use containing diclofenac sodium |
| 02/19/2008 | CA2259584C Plasters containing isosorbide dinitrate |
| 02/19/2008 | CA2237023C Improved formulation for administration of steroid compounds |
| 02/19/2008 | CA2218553C 2,4-dichlorobenzyl alcohol and amylmetacresol against hiv infection |
| 02/19/2008 | CA2199004C Preparation of multivesicular liposomes for controlled release of active agents |
| 02/19/2008 | CA2197210C Intravenous alendronate formulations |
| 02/19/2008 | CA2162260C Methods and formulations for use in treating oophorectomized women |
| 02/19/2008 | CA2132613C Method and compositions for enhancing white blood cell functioning on a mucosal or cutaneous surface |
| 02/14/2008 | WO2008019254A2 Reagents, methods and systems to suppress pro-inflammatory cytokines |
| 02/14/2008 | WO2008019198A1 Steroid-containing sustained release intraocular implants and related methods |
| 02/14/2008 | WO2008019136A2 Transdermal atomoxetine formulations and associated methods |
| 02/14/2008 | WO2008019109A2 Stabilization of lorazepam |
| 02/14/2008 | WO2008018872A1 Therapeutic methods of using estrogen compositions |
| 02/14/2008 | WO2008018825A1 Oral polyvinyl alcohol capsules comprising proton pump inhibitors |
| 02/14/2008 | WO2008018796A2 Viscoelastic aqueous gels comprising microspheres |
| 02/14/2008 | WO2008018592A1 External preparation comprising prostaglandin derivative |
| 02/14/2008 | WO2008018569A1 Pharmaceutical composition |
| 02/14/2008 | WO2008018561A1 Process for production of spherical granule containing slightly water-soluble substance |
| 02/14/2008 | WO2008018556A1 Tablet |
| 02/14/2008 | WO2008018555A1 HBsAg PARTICLE HAVING LOW ANTIGENICITY AND METHOD FOR PRODUCTION THEREOF |
| 02/14/2008 | WO2008018371A1 Oral disintegrating tablet having masked bitter taste and method for production thereof |
| 02/14/2008 | WO2008018086A1 Mouth dissolving pharmaceutical or nutraceutical composition |
| 02/14/2008 | WO2008017521A2 Compositions with enhanced elasticizing activity |
| 02/14/2008 | WO2008017472A2 Method for the production of a porous, ceramic surface layer |
| 02/14/2008 | WO2008017337A1 Pharmaceutical composition comprising an active ingredient which neutralizes and/or binds gastric acid, such as an alginic acid derivative |
| 02/14/2008 | WO2008017335A2 Starch silica co-precipitate, method for preparing the same and use thereof |
| 02/14/2008 | WO2008017334A2 Microemulsified drug formulation |
| 02/14/2008 | WO2008017331A2 Peroral drug form comprising dienogest and ethinyl estradiol for contraception |
| 02/14/2008 | WO2008017247A1 A biodegradable polyester containing phosphatidylcholine groups and its preparation |
| 02/14/2008 | WO2008017170A1 Biomedical polymer material for tissue repair and engineering |
| 02/14/2008 | WO2008005543A3 Compositions with controlled pharmacokinetics |
| 02/14/2008 | WO2007149773A3 Punctal plugs for the delivery of active agents |
| 02/14/2008 | WO2007144084A8 Type-2 diabetes combination wafer |
| 02/14/2008 | WO2007143959A3 Tablet containing metformin |
| 02/14/2008 | WO2007143131A9 Prednisolone sodium phosphate formulations |
| 02/14/2008 | WO2007143061A3 Prednisolone salt formulations |
| 02/14/2008 | WO2007138557A3 Controlled-release multiple unit pharmaceutical compositions |
| 02/14/2008 | WO2007135224A3 Method for storing silica-based material, package produced with the method and use of package for packaging of silica-based products |
| 02/14/2008 | WO2007125533A3 Orally administrable films and preparation thereof |
| 02/14/2008 | WO2007115381B1 Solid dispersion of poorly soluble drugs in graft copolymers |
| 02/14/2008 | WO2007103534A3 Ethyl nitrite as a gastrointestinal smooth muscle relaxant and diagnostic and therapeutic uses thereof |
| 02/14/2008 | WO2007092582A3 Neutralization of bacterial spores |
| 02/14/2008 | WO2007090408A3 Coated tablets, their methods of preparation, and related uses |
| 02/14/2008 | WO2007089934A3 Methods of treating alcoholism and alcohol related disorders using combination drug therapy and swellable polymers |
| 02/14/2008 | WO2007087418A3 Composition and method for neuromuscular blockade |
| 02/14/2008 | WO2007060208A8 Fast-dissolving isotropic expanded microporous composition or structure for pharmaceutical, veterinary, dietetic, food or cosmetic use and method for obtaining same |
| 02/14/2008 | WO2007016435A3 Method to improve characteristics of spray dried powders and granulated materials, and the products thereby produced |
| 02/14/2008 | WO2007005633A8 Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate |
| 02/14/2008 | WO2000041670A3 Pharmaceutical forms and methods for penetration continuity |
| 02/14/2008 | US20080039931 Hydrophilic shape memory insertable medical articles |
| 02/14/2008 | US20080039821 Method for estimating cardiac pressure using parameters derived from impedance signals detected by an implantable medical device |
| 02/14/2008 | US20080039533 Bioactive Compositions Comprising Triazines |
| 02/14/2008 | US20080039522 Composition Containing a Complex Comprising a Metal Ion and a Carboxylate Ligand Having Anti-Inflammatory Activity |
| 02/14/2008 | US20080039516 Composition of Solifenacin or Salt Thereof for Use in Solid Formulation |
| 02/14/2008 | US20080039422 Vitamin B12-Containing Compositions and Methods of Use |
| 02/14/2008 | US20080039396 Freeze drying an aliquot of an aqueous solution blood factor such as antihemophilic factor or blood-coagulation factor IX in the presence of trehalose stabilizer wherein the aliquot is free of albumin; hemophilia treatment |
| 02/14/2008 | US20080039381 Lactalbumin for Inhibiting Angiogenesis |
| 02/14/2008 | US20080039371 Erythropoietin Liquid Formulation |
| 02/14/2008 | US20080039366 Administering insulin, sodium citrate and phospholipid to respiratory tract |
| 02/14/2008 | US20080038403 Weight management system for obese animals |
| 02/14/2008 | US20080038371 Solid Lipid Nanoparticles comprising a hydrophilic platinum complex comprising anionic ligands and ligands containing amino groups such as trans-{bis[trans(diammine)(chloro)platinum (II) ( mu -1,6-hexanediamine)]}diammineplatinum tetranitrate salt |
| 02/14/2008 | US20080038363 Aerosol delivery system and uses thereof |
| 02/14/2008 | US20080038362 Composition For An Enteric Coating Of Natural Product Containing Lectin |
| 02/14/2008 | US20080038361 Water-Soluble Nanoparticles Stabilized with Multi-Functional Group Ligands and Method of Preparation Thereof |
| 02/14/2008 | US20080038360 Personal care composition |
| 02/14/2008 | US20080038359 Stable Nanoparticle Formulations |
| 02/14/2008 | US20080038358 Dry powder formulations of antihistamine for nasal administration |
| 02/14/2008 | US20080038357 Inhalation Powder Containing the CGRP antagonist BIBN4096 and Process for the Preparation Thereof |
| 02/14/2008 | US20080038356 Spray freeze-dried compositions |
| 02/14/2008 | US20080038355 Bioadhesive dosage form of steroids |
| 02/14/2008 | US20080038354 Polymeric matrices for the controlled release of a hydrophilic bioactive agent; hydrophilic drug delivery; side effect reduction |
| 02/14/2008 | US20080038353 Polymer Based Nano-Carriers For The Solubilization And Delivery Of Hydrophobic Drugs |
| 02/14/2008 | US20080038352 Electroprocessed Collagen and Tissue Engineering |
| 02/14/2008 | US20080038351 Flowable carrier matrix |
| 02/14/2008 | US20080038350 Low-dosage peroral medication for contraception containing crystalline dienogest and ethinyl estradiol |
| 02/14/2008 | US20080038349 Peptide-Pna Chimera Targeting Inducible Nitric Oxide Synthetase |
| 02/14/2008 | US20080038348 Modified release formulations of a bupropion salt |
| 02/14/2008 | US20080038347 Extended release tablet formulations of flibanserin and method for manufacturing the same |
| 02/14/2008 | US20080038346 Extended release tablet formulations of flibanserin and method for manufacturing the same |
| 02/14/2008 | US20080038345 Microparticles having osmotic subcoat; extended release tablets; shelf life; hydrobromide form |
| 02/14/2008 | US20080038344 Solid Pharmaceutical Preparation |
| 02/14/2008 | US20080038343 Pharmaceutical composition containing a tetrahydrofolic acid |
| 02/14/2008 | US20080038342 Stable Pharmaceutical Composition Comprising an Ace Inhibitor |
| 02/14/2008 | US20080038341 Direct Compression Formulation And Process |
| 02/14/2008 | US20080038340 Solid dosage form of enteric solid dispersion and method for producing the same |